These data are in agreement with a study demonstrating that HIF-1 levels are reduced in AD brains compared to age-matched controls, [18] resulting in decreased GLUT1 and GLUT3 levels and with abnormal tau hyperphosphorylation [3]. The gene discussed is MAPT; the disease is Alzheimer disease.